This Week in Clinical Cancer Research | GenomeWeb

In Clinical Cancer Research this week, researchers at the University of Alabama at Birmingham report that MARCKS regulates the growth and radiation sensitivity of glioma, and could serve as a novel prognostic factor of the disease. The team analyzed MARCKS levels in five glioblastoma cell lines and eight patient-derived xenografts, and found that the gene's expression was inversely correlated with glioblastoma proliferation and intracranial xenograft growth rates.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.